As you know we are currently supporting a cutting-edge drug trial of a drug called GDNF which has great potential for people with Parkinson’s.
We have already successfully recruited a number of people with Parkinson’s to take part in this ground-breaking trial but we still need more people to come forward – especially those within relatively easy reach of Bristol, where the study is taking place.
Please help us make this trial successful by reading the information below and passing the information on to anyone who may be interested in the study.
- Aim: To test whether a drug called GDNF has the potential to slow the course of Parkinson's, which is something no current treatment can do.
- Who do the researchers need? People aged between 35-75 who have had Parkinson’s for at least 5 years. You need to meet a range of specific criteria to be eligible and be able to travel regularly to Bristol.
- What is involved? This is a clinical trial of a new treatment for Parkinson’s so taking part involves in-depth assessments, complex surgery and regular visits to the research centre in Bristol for treatment and follow-up visits.
This £2million trial is funded by Parkinson's UK, with support from the Cure Parkinson's Trust and in association with the North Bristol NHS Trust.
Because GDNF is a large protein it's quite difficult to get it into the brain. In this trial participants will have surgery to implant a device that can deliver GDNF directly into the right area of the brain.
The researchers are looking for 36 people with Parkinson's, preferably living within easy reach of Bristol, to take part in this 9-month trial.
Who can take part?
As well as being aged between 35-75 and having Parkinson’s for at least 5 years, to be a suitable candidate you must also experience problems with your Parkinson's medication - in particular, 'off' periods, when the medication stops working and symptoms become severe.
People who have previously had Deep Brain Stimulation, experience severe tremor or dyskinesia, or who have dementia or significant mood problems are not suitable to take part in this study.
All reasonable expenses incurred while taking part in the study will be fully reimbursed.
What is involved?
Taking part in this study is a significant commitment as it involves regular visits to Bristol for assessments, surgery, brain scans and treatment.
Interested in taking part?
For further information please read the full details available on our website carefully and watch the videos to get a full understanding of what the study involves: www.parkinsons.org.uk/gdnf
If you decide you’d be interested in participating in the study and think you may be a suitable candidate please contact the Parkinson’s UK research team directly: email@example.com or on 0207 963 9326.
The Research Team